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Summary: A direct radioimmunoassay of the methyl ester of urinary and serum 5-hydroxy-3-indole acetic
acid is described. The antiserum, raised in a rabbit against a conjugate of bovine serum albumin with 5-
hydroxytryptamine hemisuccinamide, contained two antigenic fractions, one binding N-acyl 5-hydroxytrypt-
amine, and the other binding methyl ester of 5*hydroxy-3-indole acetic acid, and N-acyl 5-hydroxytryptamine.
The N-acyl 5-hydroxytryptamine binding fraction was removed by affinity chromatography on a N-acyl 5-
hydroxytryptamine agarose gel in the presence of excess methyl ester of 5-hydroxy-3-indole acetic acid. The
antibody methyl ester of 5-hydroxy-3-indole acetic acid complexes were dissociated and this affinity-purified
antiserum was used in all experiments. Polyethylene glycol in combination with goat anti-rabbit IgG was
used to separate bound and unbound 125I-labeled Bolton-Hunter reagent- 5-hydroxytryptamine conjugate.
Sample preparation (esterification of 5-hydroxy-3-indole acetic acid to its methyl ester) was performed with
trimethylsilyldiazomethane in dioxane. In the analysis of urine, the reagents used in the methylation served
s diluents, contributing to the fiii l dilution of l : 1100. In the analysis of serum, a deproteination step
(ethanol precipitation) prior to methylation was necessary to obtain reproducible results. The methylated 5-
hydroxy-3-indole acetic acid was then extracted with ethyl acetate and the extract redissolved in assay buffer.
The minimal detectable concentration of methyl ester of 5-hydroxy-3-indole acetic acid was 1.1 μιηοΐ/l
(0.21 mg/1 5-hydroxy-3-indole acetic acid) urine or 100 fmol/tube. The intra-assay precision (CV) for urine
samples was 6.4% (n = 20) at a level of 22 jimol/l, and 9.6% (n = 20) at a level of 230 μπιοΐ/ΐ. The inter-
assay CV was 1 1 % at a level of 230 μιηοΐ/ΐ. The only substance crpss-reacting with the antibody was N-
acetylserotonin which was not detectable in urine when the esterification step was omitted. To validate the
clinical usefulness of this assay, a comparison with the commercially available BioRad® column assay was
performed. Both radioimmunoassay and fluorescence determination accurately identified two patients with
known carcinoid syndrome. A correlation of r = 0.817 was demonstrated between the two assays in a
comparison of normal and pathological urines. A simultaneous determination of serotonin and its metabolite
5-hydroxy-3-indole acetic acid in normal and pathological sera showed that both parameters were raised in
carcinoid syndrome.
reactjon to gjve false-positive results (4). Attempts
Carcinoid tumours generally secrete various amounts were made to overcome this problem by a combina-
of indoles. Many of thena secrete other substances tion of ion exchange chromatography and fluorome-
such s bradykinin, corticotropin, and histamine (1), try (BioRad® column test). This method, however,
but carcinoid syndrome is generally characterized by lacks sensitivity and is time consuming. Recently,
an increased urinary excretion of 5-hydroxy-3-indole high performance liquid Chromatographie analyses of
acetic acid, the end product of serotonin metabolism 5-hydroxy-3-indole acetic acid with fluorometry in
(2). Traditionally, this compound is assayed by diazo- the ultraviolet region of the spectrum (5) or electro-
tization with nitrosonaphthol to form a purple^colour chemical detection (6) have been described. Both
(3). However, it is well documented that many Other methods require solvent extraction because of the
substances present in the urine interfere with this numerous interfering compounds present in urine.
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Although the induction of antibodies against 5-hy-
droxy-3-indole acetic acid has been reported, the low
titers of anti-5-hydroxy-3-indole acetic acid antisera
(7, 8) or the complexity of the assay procedure (9)
has strictly limited their applicability. Based on the
previously described radioimmunoassay of N-acetyl-
ated 5-hydroxytryptamine (10), it was therefore de-
cided to establish a radioimmunoassay for the deter-
mination of the methyl ester of 5-hydroxy-3-indole
acetic acid in urine and serum, using a structurally
related [l25I]N-acyl analogue of 5-hydroxytryptamine.
The specific conversion of 5-hydroxy-3-indole acetic
acid into its methyl ester by trimethylsilyldiazome-
thane (11) and the use of a 125I analogue äs radio-
active ligand in combination with the double anti-
body technique facilitate the determination of 5-hy-





(125I-labeled Bolton-Hunter reagent, 74 TBq/mmol) and 5-hy-
droxy[l,2-3H(N)]tryptamine: creatinine sulphate (1.1 TBq/
mmol) were from New England Nuclear Corp. (Dreieich,
F. R. G.)· Bovine serum albumin was from Behring Institut
(Marburg, F. R. G.)· 5-Hydroxy-3-indole acetic acid and its
analogues were from Sigma (München, F. R. G.) and Aldrich
(Nettetal, F. R. G.)- Analytical grade chemicals and glass-dis-
tilled water were used throughout.
Buffers
Buffers used are identified by the following abbreviations: buf-
fer A (50 mmol/1 potassium phosphate, pH 7.0, containing
3 mmol/1 sodium azide and l g/l ascorbic acid); buffer B (buffer
A supplemented with l g/l gelatine).
Tracer solution
Appropriate amounts of the 125I-labeled Bolton-Hunter reagent-
5-hydroxytryptamine conjugate diluted with buffer B to a final
radioactivity of 10 MBq/1.
Antiserum solution
The affinity purified antiserum was tested at different dilutions
in buffer A. The dilution resulting in 25% binding of the tracer
under assay conditions was used.
Precipitating antiserum reagent
The precipitating antiserum (goat anti-rabbit IgG, polyethylene
glycol 4000, sodium azide äs preservative) was purchased from
DDV Diagnostika (Marburg, F. R. G.).
Preparation of immunogen and immunisation
The immunogen used consisted of 5-hydroxytryptamine hemi-
succinamide bound to bovine serum albumin äs described (9,
11). Rabbits were immunized with an initial dorsal injection of
an emulsion of 0.5 ml (l mg) of immunogen and 0.5 ml of
complete Freunds adjuvant. Booster injections were given in the
same way at 4 week interväls except that incomplete Freund**
adjuvant was used.
lodination of 5^hydroxytryptamine (125I-labeled Bolton-Hunter
reagent-5-hydroxytryptamine conjugate). Fivemg of 5-hydroxy-
tryptamine were dissolved in 500 dry pyridine, 10 aliquots
of this solution were mixed with appropriate amounts of I25I-
labeled Bolton-Hunter reagent and the conjugate purified by
reversed phase high performance liquid chromatogcaphy äs
previously described (10).
Purification of anti-methyl ester of 5-hydroxy-3-indole acetic acid
antibodies (affinity purified antiserum)
I. Preparation of 5-hydroxytryptamine affinity gel
Commercially available Affigel 10 (BioRad, Richniond, USA),
a N-hydroxysuccinamide active ester derivative of cross4inked
agarose beads, was used äs activated support. 5-HydroxytrypN
amine hydrochloride (500 mg plus 1.8 MBqpHJS-hydroxytryptr
amine; final specific activity 0.66 GBq/mol) was dissolved in
20 ml of l mol/1 NaOH and the free amine was extracted three
times with 50 ml of CHCl^. The organic solvent was evaporated
in vacuo and the remaining oil dissolved in ethanpl. The final
eoncentration of 5-hydroxytryptamine was l mol/1. Affigel 10
was used without fürther purification. 5-Hydroxytryptamine
solution (2 ml) was added to a Suspension of 25 ml gel in 25 ml
ethanol and the reaction mixture was gently shakeri overnight
at 4 °C. The gel was recovered by filtration and washed with
21 of buffer A. Based on the specific activity of the affinity gel
(determined after solubilization of 0.5 ml of gel Suspension with
30% H2O2), approximately 5 tnmol 5-hydroxytryptamine were
covalently bound per litre öf gel. In the presence of l g/l
ascorbic acid the gel was stable for several months at 4 °C.
II. Affinity chromatogräphy
Affinity chromatogräphy was performed äs previously de-
scribed (12). Briefly, 10 ml of antiseruni were diluted with 90 ml
of buffer A and incubated with l mg/1 of methyl ester of 5^
hydroxy-3-indole acetic acid for 2 h at 37 °C. Affinity gel (l g)
was added and the mixture rotated for 18h at 4°C. The
Suspension was poufed into a sintered glass funnel and the
filtrate collected. In order to remove excess methyl ester of 5-
hydroxy-3-indole acetic acid, the eluate was incubated for 5 h
with 5 ml of protein A sepharose (Pharmacia, Sweden), fol-
lowed by a short washing step in a sintered glass funnel. To
release the protein A-bound IgG, the affinity gel was eluted
with two volumes of 0.1 mol/1 acetic acid. The eluate was
collected directly into 0.5 mol/1 disodium phosphate to neutra-
lize the pH (13), 10 ml of rabbit preimmune serum were added,
and the solution was dialysed against phosphate buffered saline,
then lyophilized. The lyophilized anti-methyl ester of 5-hydro-
xy-3-indole acetic acid antibody-enriched serum (affinity puri^
fied antiserum) was dissolved in 10 ml of distilled water and
stored at -20 °C until use.
Sample preparation
Urine
Aliquots of acidified 24 h urine were stored in the dark at about
4 °C, or frozen if analysis was more than 48 h later. Lyophilized
quality control samples (Lypho Check®, Anaheim, California,
USA) were reconstituted with 0.1 moi/1 HC1 and stored frozen
at-20°C.
Conversion of 5-hydroxy-3*indole acetic acid to its methyl ester
Urine specimens (100 ) were diluted with 2 ml of methanoL
f his diluted urine (100 ) was added to a conical glass tube,
followed by 25 of a 18% solution p'f trimethylsilyldiazome-
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thane in dioxan (Ventron, Karlsruhe, F. R. G.)* Excess reagent
was destroyed by addition of 25 μΐ of 0.1 mol/1 HCL The
methyiated probe was then further diluted with 5 ml of buffer
B, and 100 μΐ aliquots were withdrawn for radioimmunoassay.
Serum
To avoid clotted fibrin, blood samples were collected by use of
Monovette® syringes (Sarstedt, N rabrecht, F. R. G. or similar
products), and centrifuged at 1500 g. The serum was separated
and frozen at — 20 °C before analysis (within two weeks). All
samples were taken only during normal waking hours, but at
no specific time.
5-Hydroxy-3-indole acetic acid extraction and conversion to its
methyl ester
Serum (200 μΐ) and ethanol (400 μΐ) were added to a glass tube
and carefully vortexed. The mixture was kept for 30 min at
4 °C to complete the precipitation of proteins, then centrifuged
at 2000 g. Clear supernatant (400 μΐ) was decanted into a glass
tube. Methanol (200 μΐ) and 18% trimethylsilyldiazomethane
in dioxan (50 μΐ) were added and the mixture kept for 10 min
at room temperature. HC1 (0.1 mol/1, 50 μΐ) and water (2ml)
were added and the methyiated 5-hydroxy-3-indole acetic acid
extracted with 4 ml of ethyl acetate. An aliquot of the organic
extract (3ml) was withdrawn and the solvent removed by
evaporation under a gentle stream of nitrogen. Assay buffer
(250 μΐ) was added and the 2.5-fold diluted extract stored at
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Fig. l. Inhibition by 5-hydroxytryptamine analogues of bind-
ing of 125I-labeled £0//0«-#wnter-5-hydroxytryptamine
conjugate by antibody.
Aliquots of diluted antiserum (100 μΐ) were incubated
in triplicate with tracer solution (100 μΐ, l kBq/tube)
and increasing concentrations (0—5 μηιοΐ/l) of the va-
rious competitors. Antibody-bound radioactivity was
determined by use of the double antibody technique.
The numbers represent: (1) 5-hydroxy-3-indole acetic
acid; (2) 5-hydroxytryptophol; (3) methyl ester of 5-
hydroxy-3-todole acetic acid; (4) 5-hydroxytryptamine
(non-radioactive olton-Hunter-5-hydrox.ytryptamine
conjugate, see table 2).
Radioimmunoassay procedure
The methyiated urine or serum preparation (100 μΐ), tracer
solution (100 μΐ, l kBq/tube) and diluted affinity purified anti-
serum (100 μΐ, final dilution l: 600) were added to a polystyrene
tube and incubated overnight at 4 °C. One ml of precipitating
antibody was added, the mixture incubated for l h at 4 °C and
centrifuged. The supernatant was aspirated and the pelleted
radioactivity determined in a gamma-couiiter. Each series con-
sisted of a Standard curve (0.0052—0.52 μιϊιοΐ/ΐ methyl ester of
5-hydroxy-3-indole acetic acid), blanks for the determination
of unspecific binding, quality control samples and the samples
to be assayed. The serum values were cofrected for dilution
during sample preparation by multiplying by 2.5.
Results
Antibody preparation
Approximately 50 percent pf the previously reported
polycloiial anti N-acetylserotonin antibodies re able
to bind methyl ester f 5-hydroxy-3rindole acetic acid
with high affinity (flg. 1) whereas all antibodies are
able to bind N-acyl analogues of 5-hydroxytrypt-
mine (10). This property was used to separate the
methyl ester of 5-hydroxy-3-iiidole acetic aeid binding
fraction from the exclusively N-acyl 5-hydroxy-
tryptamine binding fraction <by affinity chromatogra-
phy. As the affinity gel consisted of 5-hydroxytrypt-
amine coupled to activated carboxyl groups of cross-
linked agarose, only the N-acyl 5*hydroxytryptamine
binding fraction was retained on the gel in the pre-
sence of excess methyl ester of 5-hydroxy-3-indole
acetic acid.
The methyl ester of 5-hydroxy-3-indole acetic acid-
masked antibody fraction was isolated by a second
affinity chromatography Step. As protein A sepharose
specifically binds to the Fc region of the IgG mole-
cule, a dialysis step was necessary to isolate methyl
ester of 5-hydroxy-3-indole acetic acid-free antibod-
ies. The affinity purified antibodies were supple-
mented with preimmune serum to enhance the preci-
pitation efficiency of the second anti-rabbit IgG anti-
bodies during the radioimmunoassay procedure.
Esterification of 5-hydroxy-3-indole acetic
acid to its methyl ester
The esterification of indole acids with trimethylsilyl-
diazomethane and methanol proceeds instan-
taneously when an excess of the reagent is used,
and the reaction can be easily monitored by the
disappearance of the yellow colour (tab. 1). For di-
luted urine specimens, most of the reagent was needed
to destroy the hydrochloric acid which was added to
the urine to stabilize the 5-hydroxy-3-indole acetic
acid. Saponification of the ester bond under assay
conditions was not observed.
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A general experimental procedure for the preparation of methyl
esters is s follows: Trimethylsilyldiazomethane (0.13 mmol) in
100 μΐ of dioxan was added to a stirred solution of the carbox-
ylic acid (0.1 mmol) in methanol (5 ml) at room temperature.
The mixture was concentrated and the purity was checked by
thin-layer chromatography on Merck F-254® (Merck,
Darmstadt, F. R. G.) precoated silica gel plates in solvent Sys-
tems chloroform/methanol (9 + 1, by vol.), ethyl acetate/
ethanol/NH3 (5 + 5 + 1), and w-butanol/acetic acid/H2O
(12 + 3 + 4, by vol.).
Standard curve
A typical Standard curve is shown in figure2. The
Standard curve is sigmoid over the r nge of 0.47—47
pmol/tube. As the sample preparation includes a
1100-fold dilution of urme specimen, the Standard
curve actually covers the r nge of 5.2—520 μπιοΐ/ΐ
urine.
5.2 .52 520
5-Hydroxy-3-indote acetic acid ίμηηοΐ/ΐ]
Fig. 2. Typical Standard curve for the radioimmunoassay of
methyl ester of 5-hydroxy-3-indole acetic acid.
The abscissa represents the concentrations of methyl
ester of 5-hydroxy-3-indole acetic acid in the Standards
corrected for the 1100-fold dilution of urine during
sample preparation.
Minimum detectable concentration
The within-day CV of the zero-dose Standard is
< 2%. Therefore, the minimal detectable concentra-
tion is the concentration at which B/B0 is approxi-
mately 0.96 (l -2 CV), or 1.1 μιηοΐ/ΐ urine (0.1 pmol/
tube).
Specificity
The specificity of antibody for methyl ester of 5-
hydroxy-3-indole acetic acid is shown in table 2. The
data indicate that in addition to acylation of the
amino group of 5-hydroxytryptamine (10), esterifica-
tion of the carboxy group of .fj-hydroxy-3-indole
acetic acid is also a prerequisite for the specific recog^
nition of the 5-hydroxyindole nucleus by this anti-
body.





5-Hydroxy-3-indole acetic acid methyl ester 100 -
5-Hydroxy-3-indole acetic acid < 0.1
Indole-3-acrylic acid < 0.01
Indole-3-acrylic acid methyl ester < 4
Indole-3-pyruvic acid < 0,01
Indole-3-pyruvic acid methyl ester < 0.4
Indole-3-acetic arid < 0.1
Indole-3-acetic acid methyl ester < 2











D,L-Vanillylmandelic acid < 0.01
D,L-Vanillylniandelic acid methyl ester < 0.01
*) The percent cross reaction is determined by dividing the
mass of methyl ester of 5-hydroxy-3-indole acetic acid at
0.5 B/B0 by the mass of the cross-reacting compound at 0.5
B/B and midtiplying by 100.
The specificity of antibody for methyl ester of 5-
hydroxy-3-indole acetic acid in methylated serum ex-
tracts is shown in figure 3. Reversed phase high per-
formance liquid chromatography reveals only one
peak detectable by radioimmunoassay. The retention
time of this peak is identical with that of authentic
methyl ester of 5-hydroxy-3-indole acetic aeid.
Recovery
Urine
Twenty different urine specimens were tested. Ali-
quots were enriched witfa 26 and 52 μιηοΐ/ΐ 5-hydroxy-
3-indole acetic acid, and the differences between en-
riched and normal urines determined by radioim-
munoassay. Analytical recoveries were 99% (SD
5.4%) and 101% (SD 7.4%), respectively.
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Tab. 3. Comparison of 5-hydroxy-3-indole acetic acid radioim-










Fig. 3. High performance liquid chromatography of a human
serum extract (carcinoid syndrome).
Human serum (1 ml) and ethanol (2 ml) were mixed,
the precipitated proteins removed by centrifugation and
the supernatant methylated and extracted with ethyl
acetate s described in Material and Methods. In con-
trast to the radioimmunoassay procedure, the methyl-
ated extract was redissolved in water/methanol (9 + 1,
by vol.) and submitted to reversed phase high perform-
ance liquid chromatography on a PEP RPC column
(Pharmacia, Freiburg, F. R. G.). Fractions of 1 ml were
collected for the determination of methyl ester of 5-
hydroxy-3-indole acetic acid by radioimmunoassay. The



























































































Patients with known carcinoid syndrome
Lyphocheck® Control Urine II, Lot. No. 00200
Values in square brackets were not used for the determina-
tion of the correlation coefficient
thyl ester of 5-hydroxy-3-indole acetic acid.
Serum
Pooled human serum was enriched with 0.52 and
2.6 μιηοΐ/ΐ 5-hydroxy-3-indole acetic acid, and the
differences between enriched and pooled sera deter-
mined by radioimmunoassay. Analytical recovery
was > 85%.
Precision
Twenty urine specimeris from a normal volunteer and
Lypocheck® Contrpl Urine II C (Lot. No. 00200)
were stored in the dark at —20 °C and used to esti-
mate the intra- and iriter-assay precision. The intra-
assay CV for 22 μmQl/l (normal volunteer) and 230
μπιοΐ/ΐ (control urine) was 6.4% and 9.6%, respec-
tively (29 consecutive determinations). The inter-as-
say CV was 11% for 230 μτηοΐ/ΐ.
Fluorescence assay of uririary 5-hydroxy-3-
indole acetic acid
A comparison pf the BioRad® column test (a combi·^
nation of ion exchange chromatography and chemical
transformation of the partly purified acid to a fluo-
rochrome with subsequent fluorescence measure-
ment) and the radioimmunoassay showed the follow-
ing correlation between both methods (tab. 3). Linear
regression analysis of the data: r = 0.842, y-intercept
= 7.3, slope = 0.817.
Tab. 4. Determination of 5-hydroxy-3-indole acetic acid in ur-































a) Determined by a commercially available radioimmunoassay
(DDV Diagnostika, Marburg, F. R. G.)
b) See Table 3.
Discussion
We determined 5-hydroxy-3-indole acetic acid by ra-
dioimmunoassay, because this method is faster, more
sensitive and more specific than previously described
methods (1—9). The determination of the methyl
ester of 5-hydroxy-3-indole acetic acid has several
additional advantages: firstly, esterification prior to
radioimmunoassay strictly limits the number of pos-
sible cross-reacting compounds to carboxylic acids;
secondly, endogenous N-acetylserotonin, a minor
metabolite of 5-hydroxytryptamine (14), which could
falsify the assay is detectable by direct comparison
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of esterified and normal urine. Nevertheless, neither
N-acetylserotonin nor any other cross-reacting un-
known substance was found in normal and pathologi-
cal urines under assay conditions.
The present investigation shows that the radiöim-
munoassay of esterified 5-hydroxy-3-indole acetic
acid is highly sensitive for the analysis of 5-hydroxy-
3-indole acetic acid in a variety öf urine samples äs
well äs in serum. The good coefficients of Variation
exhibited by the method should facilitate the exam-
ination and comparison of groups that differ only
slightly from one another with respect to 5-hydroxy-
3-indole acetic acid levels. r
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